These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 8041880)
1. Can we agree on a prescription? A view from the perspective of the developing countries. Stoeckel P Public Health Rev; 1993-1994; 21(1-2):139-42. PubMed ID: 8041880 [TBL] [Abstract][Full Text] [Related]
2. Methods for poliomyelitis eradication: is there a consensus? Beale AJ Public Health Rev; 1993-1994; 21(1-2):129-34. PubMed ID: 8041878 [TBL] [Abstract][Full Text] [Related]
3. The cost-effectiveness of alternative polio immunization policies in South Africa. Griffiths UK; Botham L; Schoub BD Vaccine; 2006 Jul; 24(29-30):5670-8. PubMed ID: 16766096 [TBL] [Abstract][Full Text] [Related]
4. An end to Manicheism. Plotkin SA Public Health Rev; 1993-1994; 21(1-2):135-8. PubMed ID: 8041879 [TBL] [Abstract][Full Text] [Related]
5. Cost analysis of post-polio certification immunization policies. Sangrujee N; Cáceres VM; Cochi SL Bull World Health Organ; 2004 Jan; 82(1):9-15. PubMed ID: 15106295 [TBL] [Abstract][Full Text] [Related]
6. A developing country perspective on vaccine-associated paralytic poliomyelitis. John TJ Bull World Health Organ; 2004 Jan; 82(1):53-7; discussion 57-8. PubMed ID: 15106301 [TBL] [Abstract][Full Text] [Related]
7. Poliomyelitis in selected African and Asian countries. Patriarca PA Public Health Rev; 1993-1994; 21(1-2):91-8. PubMed ID: 8041892 [TBL] [Abstract][Full Text] [Related]
8. Can we agree on a prescription? Summary of the open discussion. Patriarca PA Public Health Rev; 1993-1994; 21(1-2):161-4. PubMed ID: 8041885 [No Abstract] [Full Text] [Related]
12. The challenge of changing the inactivated poliomyelitis vaccine in Latin America: declaration of the Latin American Society of Pediatric Infectious Diseases (SLIPE). Falleiros-Arlant LH; Avila-Agüero ML; Brea del Castillo J; Mariño C Rev Chilena Infectol; 2014 Oct; 31(5):590-603. PubMed ID: 25491459 [TBL] [Abstract][Full Text] [Related]
13. Public health. Is polio eradication realistic? Arita I; Nakane M; Fenner F Science; 2006 May; 312(5775):852-4. PubMed ID: 16690846 [No Abstract] [Full Text] [Related]
14. Economics of polio vaccination in the post-eradication era: should OPV-using countries adopt IPV? Khan MM Vaccine; 2008 Apr; 26(16):2034-40. PubMed ID: 18339460 [TBL] [Abstract][Full Text] [Related]
15. Global health. Polio eradication: is it time to give up? Roberts L Science; 2006 May; 312(5775):832-5. PubMed ID: 16690830 [No Abstract] [Full Text] [Related]
16. The costs of future polio risk management policies. Tebbens RJ; Sangrujee N; Thompson KM Risk Anal; 2006 Dec; 26(6):1507-31. PubMed ID: 17184394 [TBL] [Abstract][Full Text] [Related]
17. Basic conditions for the eradication of poliomyelitis--indications for a common prescription. Swartz TA Public Health Rev; 1993-1994; 21(1-2):157-60. PubMed ID: 8041884 [TBL] [Abstract][Full Text] [Related]
19. Poliomyelitis in the United States: the final chapter? Modlin JF JAMA; 2004 Oct; 292(14):1749-51. PubMed ID: 15479943 [No Abstract] [Full Text] [Related]
20. Polio endgame: the global introduction of inactivated polio vaccine. Patel M; Zipursky S; Orenstein W; Garon J; Zaffran M Expert Rev Vaccines; 2015 May; 14(5):749-62. PubMed ID: 25597843 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]